Table of contents
Volume 96, Issue 9
Published online 1 May 2007 (1315-1492)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor |
Corrigendum |
Erratum
Reviews
Exploiting nanotechnology to target cancer FREE
S Sengupta and R Sasisekharan
Br J Cancer 96: 1315-1319; advance online publication, April 3, 2007; doi:10.1038/sj.bjc.6603707
Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer FREE
M Stanley
Br J Cancer 96: 1320-1323; advance online publication, March 20, 2007; doi:10.1038/sj.bjc.6603695
Clinical Studies
Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease FREE
J S Kim, S J Chung, Y S Choi, J H Cheon, C W Kim, S G Kim, H C Jung and I S Song
Br J Cancer 96: 1324-1328; advance online publication, April 3, 2007; doi:10.1038/sj.bjc.6603708
Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients FREE
U Haug, D Rothenbacher, M N Wente, C M Seiler, C Stegmaier and H Brenner
Br J Cancer 96: 1329-1334; advance online publication, April 3, 2007; doi:10.1038/sj.bjc.6603712
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study FREE
B B J Hermsen, R I Olivier, R H M Verheijen, M van Beurden, J A de Hullu, L F Massuger, C W Burger, C T Brekelmans, M J Mourits, G H de Bock, K N Gaarenstroom, H H van Boven, T M Mooij and M A Rookus
Br J Cancer 96: 1335-1342; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603725
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation FREE
P Correale, A Sciandivasci, C Intrivici, A Pascucci, M T Del Vecchio, S Marsili, V Savelli, L Voltolini, M Di Bisceglie, A Guarnieri, G Gotti and G Francini
Br J Cancer 96: 1343-1347; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603734
First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study FREE
E van Meerten, F A L M Eskens, E C van Gameren, L Doorn and A van der Gaast
Br J Cancer 96: 1348-1352; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603750
Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer FREE
H Shinchi, K Maemura, H Noma, Y Mataki, T Aikou and S Takao
Br J Cancer 96: 1353-1357; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603735
Translational Therapeutics
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer FREE
A Mercalli, V Sordi, R Formicola, M Dandrea, S Beghelli, A Scarpa, V Di Carlo, M Reni and L Piemonti
Br J Cancer 96: 1358-1367; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603726
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol FREE
S K Chander, P A Foster, M P Leese, S P Newman, B V L Potter, A Purohit and M J Reed
Br J Cancer 96: 1368-1376; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603727
Molecular Diagnostics
Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence FREE
E A Griffiths, S A Pritchard, S M McGrath, H R Valentine, P M Price, I M Welch and C M L West
Br J Cancer 96: 1377-1383; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603744
Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer FREE
T J Dudderidge, S R McCracken, M Loddo, T R Fanshawe, J D Kelly, D E Neal, H Y Leung, G H Williams and K Stoeber
Br J Cancer 96: 1384-1393; advance online publication, April 3, 2007; doi:10.1038/sj.bjc.6603718
PTHrP increases transcriptional activity of the integrin subunit 
5
FREE
J A Anderson, A M Grabowska and S A Watson
Br J Cancer 96: 1394-1403; advance online publication, April 3, 2007; doi:10.1038/sj.bjc.6603720
In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin FREE
A Batistatou, D Peschos, H Tsanou, A Charalabopoulos, Y Nakanishi, S Hirohashi, N J Agnantis and K Charalabopoulos
Br J Cancer 96: 1404-1408; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603743
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX FREE
O Nehls, T Okech, C-J Hsieh, T Enzinger, M Sarbia, F Borchard, H-H Gruenagel, V Gaco, H G Hass, H T Arkenau, J T Hartmann, R Porschen, M Gregor and B Klump
Br J Cancer 96: 1409-1418; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603728
High-risk HPV type-specific clearance rates in cervical screening FREE
N W J Bulkmans, J Berkhof, S Bulk, M C G Bleeker, F J van Kemenade, L Rozendaal, P J F Snijders and C J L M Meijer on behalf of the POBASCAM Study Group
Br J Cancer 96: 1419-1424; advance online publication, March 6, 2007; doi:10.1038/sj.bjc.6603653
The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma FREE
G Bradley, S Tremblay, J Irish, C MacMillan, G Baker, P Gullane and S Benchimol
Br J Cancer 96: 1425-1432; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603745
Epidemiology
Twin births, sex of children and maternal risk of ovarian cancer: a cohort study in Norway FREE
G Albrektsen, I Heuch, S Thoresen and G Kvåle
Br J Cancer 96: 1433-1435; advance online publication, March 27, 2007; doi:10.1038/sj.bjc.6603687
The negative association between pre-eclampsia and breast cancer risk may depend on the offspring's gender FREE
L J Vatten, M R Forman, T I L Nilsen, J C Barrett and P R Romundstad
Br J Cancer 96: 1436-1438; advance online publication, March 27, 2007; doi:10.1038/sj.bjc.6603688
Offspring sex ratio and gonadal irradiation in the British Childhood Cancer Survivor Study FREE
R C Reulen, M P Zeegers, E R Lancashire, D L Winter and M M Hawkins on behalf of the British Childhood Cancer Survivor Study
Br J Cancer 96: 1439-1441; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603736
Post-treatment parenthood in Hodgkin's lymphoma survivors FREE
C E Kiserud, A Fosså, H Holte and S D Fosså
Br J Cancer 96: 1442-1449; advance online publication, April 3, 2007; doi:10.1038/sj.bjc.6603711
Reproductive risk factors for endometrial cancer among Polish women FREE
L A Brinton, L C Sakoda, J Lissowska, M E Sherman, N Chatterjee, B Peplonska, N Szeszenia-Dabrowska, W Zatonski and M Garcia-Closas
Br J Cancer 96: 1450-1456; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603731
Obesity and the risk of gallbladder cancer: a meta-analysis FREE
S C Larsson and A Wolk
Br J Cancer 96: 1457-1461; advance online publication, March 20, 2007; doi:10.1038/sj.bjc.6603703
Comorbidity and survival of Danish breast cancer patients from 1995 to 2005 FREE
D P Cronin-Fenton, M Nørgaard, J Jacobsen, J P Garne, M Ewertz, T L Lash and H T Sørensen
Br J Cancer 96: 1462-1468; advance online publication, April 3, 2007; doi:10.1038/sj.bjc.6603717
Alcohol and head and neck cancer risk in a prospective study FREE
N D Freedman, A Schatzkin, M F Leitzmann, A R Hollenbeck and C C Abnet
Br J Cancer 96: 1469-1474; advance online publication, March 27, 2007; doi:10.1038/sj.bjc.6603713
Benign prostatic hyperplasia and subsequent risk of bladder cancer FREE
D Kang, A P Chokkalingam, G Gridley, O Nyren, J E Johansson, H O Adami, D Silverman and A W Hsing
Br J Cancer 96: 1475-1479; doi:10.1038/sj.bjc.6603730
Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia FREE
V V Sahasrabuddhe, M H Mwanahamuntu, S H Vermund, W K Huh, M D Lyon, J S A Stringer and G P Parham
Br J Cancer 96: 1480-1483; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603737
The future burden of cancer in England: incidence and numbers of new patients in 2020 FREE
H Møller, L Fairley, V Coupland, C Okello, M Green, D Forman, B Møller and F Bray
Br J Cancer 96: 1484-1488; doi:10.1038/sj.bjc.6603746
Letters to the Editor
The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer FREE
J Almond and S Ralston
Br J Cancer 96: 1489; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603738
Reply: The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer FREE
S E Ward
Br J Cancer 96: 1490; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603739
Corrigendum
EpCAM (CD326) finding its role in cancer FREE
P A Baeuerle and O Gires
Br J Cancer 96: 1491; doi:10.1038/sj.bjc.6603758
Erratum
Ovarian cancer in younger vs older women: a population-based analysis FREE
J K Chan, R Urban, M K Cheung, K Osann, J Y Shin, A Husain, N N Teng, D S Kapp, J S Berek and G S Leiserowitz
Br J Cancer 96: 1492; doi:10.1038/sj.bjc.6603757
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
